Iodine-based oral rinse - Biomedical Development Corporation

Drug Profile

Iodine-based oral rinse - Biomedical Development Corporation

Alternative Names: Frio mouth rinse; Frio oral rinse; iCLEAN/FRIO; Iocide; Iocide oral rinse

Latest Information Update: 14 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biomedical Development Corporation
  • Developer Biomedical Development Corporation; Foundation Of Collaborative Unique Science; Methodist Healthcare Ministries of South Texas; National Institute of Nursing Research
  • Class Disinfectants; Halogens
  • Mechanism of Action Endotoxin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Gingivitis
  • Phase I Candidiasis; Periodontitis; Urinary tract infections

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 14 Apr 2016 Phase-II development for Gingivitis, and phase I development for candidiasis, periodontitis and urinary tract infections, are ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top